Norway· NO-ID_77BD3B26-AED8-4E35-AC46-BA0D4124B829
Cannabidiol glostrup
A cannabidiol product containing cannabidiol, registered in Norway by Glostrup Apotek. The same ATC class is registered in 14 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Cannabidiol is registered in 14 of 19 countries.
Countries holding a registration under ATC N03AX24 (cannabidiol), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 10 of them publish a price we can compare per daily dose
Cannabidiol · ATC N03AX24
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Cannabidiol
- Manufacturer
- Glostrup Apotek
- Country
- Norway (NO)
- ATC code
- N03AX24
- ATC class
- Cannabidiol
- Defined daily dose
- 0.7 g, O
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
- no_merkevare_idID_77BD3B26-AED8-4E35-AC46-BA0D4124B829
- no_varenummer36110350
- gtin5762936953083
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
277 interactions on record for cannabidiol.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cannabidiol · interactions on record
277 records
- 4 severe
- 251 moderate
- 22 minor
Most severe, free to view
- ClotrimazoleA01AB18moderate
- MetoclopramideA03FA01moderate
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cannabidiol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCannabidiol 200mg/ml oral solutionSpecial Order
- CzechiaEPIDYOLEXJazz Pharmaceuticals Ireland Ltd, Dublin
- United StatesEpidiolexJazz Pharmaceuticals, Inc.
- FinlandEpidyolexJazz Pharmaceuticals Ireland Limited
- FranceEPIDYOLEX 100 mg/mL, solution buvableJAZZ PHARMACEUTICALS IRELAND LIMITED (IRLANDE)
- BelgiumEpidyolex 100 mg/mlJazz Pharmaceuticals Ireland
- IcelandEpidyolexJazz Pharmaceuticals Ireland Ltd
- ItalyEPIDYOLEX*orale soluz 100 mg/ml 100 mlJAZZ PHARMACEUTICALS IREL.LTD
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Epidyolex
- Liechtenstein · Epidyolex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd789da1-9a58-4ea5-a5f3-f07ab05acf60 GET /v1/drugs/fd789da1-9a58-4ea5-a5f3-f07ab05acf60?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dråper, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Cannabidiol",
"merkevare_id": "ID_77BD3B26-AED8-4E35-AC46-BA0D4124B829",
"name_form_strength": "Cannabidiol glostrup dråper, oppl 20 mg/ml",
"prescription_group": "A"
}See everything about cannabidiol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.